2018 Q2 Form 10-Q Financial Statement
#000114420418043318 Filed on August 09, 2018
Income Statement
| Concept | 2018 Q2 | 2017 Q2 |
|---|---|---|
| Revenue | $2.168M | $1.703M |
| YoY Change | 27.3% | -47.94% |
| Cost Of Revenue | $1.576M | $1.015M |
| YoY Change | 55.3% | -52.74% |
| Gross Profit | $591.3K | $687.7K |
| YoY Change | -14.02% | -38.76% |
| Gross Profit Margin | 27.28% | 40.39% |
| Selling, General & Admin | ||
| YoY Change | ||
| % of Gross Profit | ||
| Research & Development | $1.327M | $1.966M |
| YoY Change | -32.52% | 26.8% |
| % of Gross Profit | 224.36% | 285.86% |
| Depreciation & Amortization | $303.7K | $188.1K |
| YoY Change | 61.44% | 6.86% |
| % of Gross Profit | 51.36% | 27.36% |
| Operating Expenses | $2.450M | $2.926M |
| YoY Change | -16.28% | 23.93% |
| Operating Profit | -$1.858M | -$2.238M |
| YoY Change | -16.97% | 80.8% |
| Interest Expense | $83.14K | $70.73K |
| YoY Change | 17.54% | 2.59% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $170.6K | $73.00K |
| YoY Change | 133.74% | -96.87% |
| Pretax Income | -$1.688M | -$2.166M |
| YoY Change | -22.07% | -297.51% |
| Income Tax | $0.00 | $3.000K |
| % Of Pretax Income | ||
| Net Earnings | -$1.688M | -$2.169M |
| YoY Change | -22.18% | -297.34% |
| Net Earnings / Revenue | -77.86% | -127.37% |
| Basic Earnings Per Share | $0.00 | $0.00 |
| Diluted Earnings Per Share | $0.00 | $0.00 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 803.0M shares | 819.3M shares |
| Diluted Shares Outstanding | 803.0M shares | 819.3M shares |
Balance Sheet
| Concept | 2018 Q2 | 2017 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $5.640M | $9.570M |
| YoY Change | -41.07% | -25.29% |
| Cash & Equivalents | $5.644M | $9.962M |
| Short-Term Investments | ||
| Other Short-Term Assets | $610.0K | $250.0K |
| YoY Change | 144.0% | 13.64% |
| Inventory | $4.140M | $5.890M |
| Prepaid Expenses | ||
| Receivables | $1.062M | $720.0K |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $11.46M | $16.44M |
| YoY Change | -30.31% | -8.62% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $8.872M | $9.320M |
| YoY Change | -4.81% | 13.35% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | $7.713M | |
| YoY Change | ||
| Long-Term Investments | $60.00K | $60.00K |
| YoY Change | 0.0% | 20.0% |
| Other Assets | $452.6K | $390.0K |
| YoY Change | 16.06% | -10.89% |
| Total Long-Term Assets | $17.04M | $17.45M |
| YoY Change | -2.36% | 15.8% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $11.46M | $16.44M |
| Total Long-Term Assets | $17.04M | $17.45M |
| Total Assets | $28.50M | $33.89M |
| YoY Change | -15.92% | 2.51% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $1.065M | $880.0K |
| YoY Change | 21.07% | -39.63% |
| Accrued Expenses | $1.970M | $1.200M |
| YoY Change | 64.18% | -14.29% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $620.0K | $420.0K |
| YoY Change | 47.62% | -17.65% |
| Total Short-Term Liabilities | $4.671M | $3.510M |
| YoY Change | 33.08% | -19.85% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $3.380M | $3.460M |
| YoY Change | -2.31% | 63.98% |
| Other Long-Term Liabilities | $41.15K | $9.230M |
| YoY Change | -99.55% | 22231.91% |
| Total Long-Term Liabilities | $6.832M | $12.69M |
| YoY Change | -46.16% | -3.45% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $4.671M | $3.510M |
| Total Long-Term Liabilities | $6.832M | $12.69M |
| Total Liabilities | $11.50M | $16.20M |
| YoY Change | -29.0% | -7.55% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$144.2M | |
| YoY Change | ||
| Common Stock | $147.6M | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | $306.8K | |
| YoY Change | ||
| Treasury Stock Shares | 100.0K shares | 100.0K shares |
| Shareholders Equity | $3.089M | $17.68M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $28.50M | $33.89M |
| YoY Change | -15.92% | 2.51% |
Cashflow Statement
| Concept | 2018 Q2 | 2017 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$1.688M | -$2.169M |
| YoY Change | -22.18% | -297.34% |
| Depreciation, Depletion And Amortization | $303.7K | $188.1K |
| YoY Change | 61.44% | 6.86% |
| Cash From Operating Activities | -$1.710M | -$1.091M |
| YoY Change | 56.69% | 43.56% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$180.0K | -$340.0K |
| YoY Change | -47.06% | 21.43% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | ||
| YoY Change | ||
| Cash From Investing Activities | -$178.6K | -$335.8K |
| YoY Change | -46.83% | 19.94% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $168.2K | $423.8K |
| YoY Change | -60.31% | -82.85% |
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | $354.2K | $405.4K |
| YoY Change | -12.63% | -82.75% |
| NET CHANGE | ||
| Cash From Operating Activities | -$1.710M | -$1.091M |
| Cash From Investing Activities | -$178.6K | -$335.8K |
| Cash From Financing Activities | $354.2K | $405.4K |
| Net Change In Cash | -$1.534M | -$1.021M |
| YoY Change | 50.17% | -177.98% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$1.710M | -$1.091M |
| Capital Expenditures | -$180.0K | -$340.0K |
| Free Cash Flow | -$1.530M | -$751.1K |
| YoY Change | 103.66% | 56.47% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018Q2 | us-gaap |
Loss Contingency Disclosures
LossContingencyDisclosures
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 9. COMMITMENTS AND CONTINGENCIES</div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="white-space: pre-wrap; font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.</div></div><div style="background: none; font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="white-space: pre-line; font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></div><div style="background: rgb(255, 255, 255); font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Operating Leases – 135 Ludlow Ave.</div></div></div></div><div style="background: none; font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="background: rgb(255, 255, 255); font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company entered into an operating lease for a portion of a one-story warehouse, located at 135 Ludlow Avenue, Northvale, New Jersey (the “135 Ludlow Ave. lease”). The 135 Ludlow Ave. lease is for approximately 15,000 square feet of floor space and began on July 1, 2010. During July 2014, the Company modified the 135 Ludlow Ave. lease in which the Company was permitted to occupy the entire 35,000 square feet of floor space in the building (“135 Ludlow Ave. modified lease”).</div></div><div style="background: none; font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="background: rgb(255, 255, 255); font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The 135 Ludlow Ave. modified lease includes an initial term, which expired on December 31, 2016 with two tenant renewal options of five years each, at the sole discretion of the Company. On June 22, 2016, the Company exercised the first of these renewal options, with such option including a term that begins on January 1, 2017 and expires on December 31, 2021.</div></div><div style="background: none; font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px;"><div style="white-space: pre-line; font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="background: rgb(255, 255, 255); font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The 135 Ludlow Ave. property required significant leasehold improvements and qualifications, as a prerequisite, for its intended future use. Manufacturing, packaging, warehousing and regulatory activities are currently conducted at this location. Additional renovations and construction to further expand the Company’s manufacturing resources are in progress.</div></div><div style="background: none; font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="background: rgb(255, 255, 255); font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Rent expense is recorded on the straight-line basis. Rents paid in excess is recognized as deferred rent. Rent expense under the 135 Ludlow Ave. modified lease for the three-month ended June 30, 2018 and 2017 was $54,909. Rent expense is recorded in general and administrative expense in the unaudited condensed consolidated statements of operations. Deferred rent as of June 30, 2018 and March 31, 2018 was $10,804 and $9,702, respectively and recorded as a component of other long-term liabilities.</div></div><div> </div><div style="background: rgb(255, 255, 255); font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px;"><div style="white-space: pre-line; font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has an obligation for the restoration of its leased facility and the removal or dismantlement of certain property and equipment as a result of its business operation in accordance with ASC 410, <div style="font-style:italic;display:inline;">Asset Retirement and Environmental Obligations – Asset Retirement Obligations</div>. The Company records the fair value of the asset retirement obligation in the period in which it is incurred. The Company increases, annually, the liability related to this obligation. The liability is accreted to its present value each period and the capitalized cost is depreciated over the useful life of the related asset. Upon settlement of the liability, the Company records either a gain or loss. As of June 30, 2018, and March 31, 2018, the Company had a liability of $31,917 and $31,443, respectively and recorded as a component of other long-term liabilities.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2018Q1 | eltp |
Derivative Liability Warrants
DerivativeLiabilityWarrants
|
2667871 | USD |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6618000 | shares |
| CY2018Q1 | eltp |
Warrants Outstanding
WarrantsOutstanding
|
79008661 | shares |
| CY2017Q1 | eltp |
Warrants Outstanding
WarrantsOutstanding
|
9379219 | shares |
| CY2018Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
10016 | USD |
| CY2018Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
229204 | USD |
| CY2018Q2 | us-gaap |
Depreciation
Depreciation
|
300167 | USD |
| CY2017Q2 | us-gaap |
Depreciation
Depreciation
|
184586 | USD |
| CY2018Q2 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
77690 | USD |
| CY2018Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
297350 | USD |
| CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1687766 | USD |
| CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2168760 | USD |
| CY2018Q2 | eltp |
Warrants Granted During Period
WarrantsGrantedDuringPeriod
|
0 | shares |
| CY2018 | eltp |
Warrants Granted During Period
WarrantsGrantedDuringPeriod
|
79008661 | shares |
| CY2018Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50.000 | shares |
| CY2018Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50.000 | shares |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2018Q2 | us-gaap |
Revenues
Revenues
|
2167698 | USD |
| CY2017Q2 | us-gaap |
Revenues
Revenues
|
1702770 | USD |
| CY2018Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
0 | USD |
| CY2018Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
0 | USD |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
100000 | shares |
| CY2018Q2 | eltp |
Derivative Liability Warrants Change In Fair Value Of Warrant Liability
DerivativeLiabilityWarrantsChangeInFairValueOfWarrantLiability
|
252511 | USD |
| CY2018Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
24.0344 | shares |
| CY2018Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
24.0344 | shares |
| CY2018Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
392820 | USD |
| CY2018Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
391566 | USD |
| CY2018Q2 | eltp |
Warrant Exercised Forfeitures And Expirations During Period
WarrantExercisedForfeituresAndExpirationsDuringPeriod
|
0 | shares |
| CY2018 | eltp |
Warrant Exercised Forfeitures And Expirations During Period
WarrantExercisedForfeituresAndExpirationsDuringPeriod
|
9379219 | shares |
| CY2018Q2 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2018Q2 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
4052484 | USD |
| CY2018Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
4371447 | USD |
| CY2018Q2 | us-gaap |
Inventory Gross
InventoryGross
|
4140190 | USD |
| CY2018Q1 | us-gaap |
Inventory Gross
InventoryGross
|
4898001 | USD |
| CY2018Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1687766 | USD |
| CY2017Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2168760 | USD |
| CY2018Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
303711 | USD |
| CY2017Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
188130 | USD |
| CY2018Q2 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2018Q2 | eltp |
Warrants Outstanding
WarrantsOutstanding
|
79008661 | shares |
| CY2018Q2 | eltp |
Convertible Preferred Stock Par Value Per Share
ConvertiblePreferredStockParValuePerShare
|
0.01 | |
| CY2018Q1 | eltp |
Convertible Preferred Stock Par Value Per Share
ConvertiblePreferredStockParValuePerShare
|
0.01 | |
| CY2018Q2 | eltp |
Derivative Liability Warrants
DerivativeLiabilityWarrants
|
2415360 | USD |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6518000 | shares |
| CY2018Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
8709146 | USD |
| CY2018Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
8408979 | USD |
| CY2018Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1576399 | USD |
| CY2017Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1015060 | USD |
| CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4571552 | USD |
| CY2018Q2 | us-gaap |
Gross Profit
GrossProfit
|
591299 | USD |
| CY2017Q2 | us-gaap |
Gross Profit
GrossProfit
|
687710 | USD |
| CY2018Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
0 | USD |
| CY2018Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
0 | USD |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5635000 | shares |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.21 | pure |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.21 | pure |
| CY2018Q2 | eltp |
Convertible Preferred Stock Stated Value
ConvertiblePreferredStockStatedValue
|
1000000 | USD |
| CY2018Q1 | eltp |
Convertible Preferred Stock Stated Value
ConvertiblePreferredStockStatedValue
|
1000000 | USD |
| CY2018Q2 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
24043 | USD |
| CY2017Q2 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
21759 | USD |
| CY2018Q1 | eltp |
Warrants Outstanding Weighted Average Exercise Price
WarrantsOutstandingWeightedAverageExercisePrice
|
0.1521 | |
| CY2017Q1 | eltp |
Warrants Outstanding Weighted Average Exercise Price
WarrantsOutstandingWeightedAverageExercisePrice
|
0.0625 | |
| CY2018Q2 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-06-30 | |
| CY2018Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-252511 | USD |
| CY2017Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-139260 | USD |
| CY2018Q2 | us-gaap |
Revenue Recognition Milestone Method Milestone
RevenueRecognitionMilestoneMethodMilestone
|
The milestones, totaling $500k (with $405k already received), consist of amounts due upon the first shipment of each identified product, as follows: Phentermine 37.5mg tablets ($145k), Phentermine 15 & 30mg capsules ($45k), Hydromorphone 8mg ($125k), Naltrexone 50mg ($95k) and the balance of $95k due in relation to the first shipment of generic products which still require marketing authorizations from the FDA, and to which there can be no assurances of such marketing authorizations being granted and accordingly there can be no assurances that the Company will earn and receive these milestone amounts. | |
| CY2018Q2 | eltp |
Effect Of Dilutive Instruments On Net Income
EffectOfDilutiveInstrumentsOnNetIncome
|
0 | USD |
| CY2017Q2 | eltp |
Effect Of Dilutive Instruments On Net Income
EffectOfDilutiveInstrumentsOnNetIncome
|
0 | USD |
| CY2018Q2 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P0Y | |
| CY2018 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P0Y | |
| CY2018Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-1687766 | USD |
| CY2017Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-2168760 | USD |
| CY2018Q2 | eltp |
Accrued Compensation Non Cash
AccruedCompensationNonCash
|
953750 | USD |
| CY2017Q2 | eltp |
Accrued Compensation Non Cash
AccruedCompensationNonCash
|
923500 | USD |
| CY2018Q2 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2019 | |
| CY2018Q2 | eltp |
Warrants Granted During Period Weighted Average Exercise Price
WarrantsGrantedDuringPeriodWeightedAverageExercisePrice
|
0 | |
| CY2018 | eltp |
Warrants Granted During Period Weighted Average Exercise Price
WarrantsGrantedDuringPeriodWeightedAverageExercisePrice
|
0.1521 | |
| CY2018Q2 | eltp |
Preferred Stock Conversion Price Per Share
PreferredStockConversionPricePerShare
|
0.1521 | |
| CY2018Q1 | eltp |
Preferred Stock Conversion Price Per Share
PreferredStockConversionPricePerShare
|
0.1521 | |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.23 | pure |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.23 | pure |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.16 | |
| CY2018Q2 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.01 | |
| CY2018Q1 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.01 | |
| CY2018Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1326628 | USD |
| CY2017Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1965883 | USD |
| CY2018Q2 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
50 | shares |
| CY2018Q1 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
50 | shares |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2018Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
2012223 | USD |
| CY2018Q1 | us-gaap |
Deferred Revenue
DeferredRevenue
|
2265556 | USD |
| CY2018Q2 | eltp |
Bond Issue Costs
BondIssueCosts
|
0 | USD |
| CY2018Q1 | eltp |
Bond Issue Costs
BondIssueCosts
|
0 | USD |
| CY2018Q2 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2018Q2 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
36549 | USD |
| CY2017Q2 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
97361 | USD |
| CY2018Q2 | eltp |
Warrant Exercised Forfeitures And Expiration Weighted Average Exercise Price
WarrantExercisedForfeituresAndExpirationWeightedAverageExercisePrice
|
0 | |
| CY2018 | eltp |
Warrant Exercised Forfeitures And Expiration Weighted Average Exercise Price
WarrantExercisedForfeituresAndExpirationWeightedAverageExercisePrice
|
0.0625 | |
| CY2018Q2 | eltp |
Common Shares To Be Issued Upon Conversion
CommonSharesToBeIssuedUponConversion
|
158017321 | shares |
| CY2018Q1 | eltp |
Common Shares To Be Issued Upon Conversion
CommonSharesToBeIssuedUponConversion
|
158017321 | shares |
| CY2018Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
17581245 | USD |
| CY2018Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
17402687 | USD |
| CY2018Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
803049238 | shares |
| CY2017Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
819321321 | shares |
| CY2018Q2 | eltp |
Noncash Rent Expense And Lease Accretion
NoncashRentExpenseAndLeaseAccretion
|
1573 | USD |
| CY2017Q2 | eltp |
Noncash Rent Expense And Lease Accretion
NoncashRentExpenseAndLeaseAccretion
|
2595 | USD |
| CY2018Q2 | dei |
Entity Registrant Name
EntityRegistrantName
|
ELITE PHARMACEUTICALS INC /NV/ | |
| CY2018Q2 | eltp |
Accumulated Amortization Of Bond
AccumulatedAmortizationOfBond
|
181952 | USD |
| CY2018Q1 | eltp |
Accumulated Amortization Of Bond
AccumulatedAmortizationOfBond
|
178409 | USD |
| CY2018Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
1013333 | USD |
| CY2018Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
1013333 | USD |
| CY2018Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
| CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
0.21 | |
| CY2018Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5644053 | USD |
| CY2018Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
7179237 | USD |
| CY2018Q1 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
24.0344 | shares |
| CY2018Q2 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
24.0344 | shares |
| CY2018Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
882812 | USD |
| CY2017Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
855961 | USD |
| CY2018Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
36549 | USD |
| CY2017Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
97361 | USD |
| CY2018Q2 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
24.0344 | shares |
| CY2018Q1 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
24.0344 | shares |
| CY2018Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1061979 | USD |
| CY2018Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
675879 | USD |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.16 | |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.022 | pure |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.022 | pure |
| CY2018Q2 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
998890 | USD |
| CY2018Q1 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
1252223 | USD |
| CY2018Q2 | eltp |
Unamortization Of Bond
UnamortizationOfBond
|
-181952 | USD |
| CY2018Q1 | eltp |
Unamortization Of Bond
UnamortizationOfBond
|
-178409 | USD |
| CY2018Q2 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001053369 | |
| CY2018Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
| CY2017Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
| CY2018Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
8709146 | USD |
| CY2018Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
8408979 | USD |
| CY2018Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
8872099 | USD |
| CY2018Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
8993708 | USD |
| CY2018Q2 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
7713001 | USD |
| CY2018Q1 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
6419091 | USD |
| CY2018Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
803049238 | shares |
| CY2017Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
819321321 | shares |
| CY2018Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
386100 | USD |
| CY2017Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-212907 | USD |
| CY2018Q2 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--03-31 | |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.028 | pure |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.024 | pure |
| CY2017Q2 | eltp |
Warrant Expiration Period
WarrantExpirationPeriod
|
P10Y | |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.15 | |
| CY2018Q2 | us-gaap |
Inventory Net
InventoryNet
|
4140190 | USD |
| CY2018Q1 | us-gaap |
Inventory Net
InventoryNet
|
4898001 | USD |
| CY2018Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
203704 | USD |
| CY2017Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
6776 | USD |
| CY2018Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2449693 | USD |
| CY2017Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2925981 | USD |
| CY2018Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
995000000 | shares |
| CY2018Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
995000000 | shares |
| CY2018Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
611305 | USD |
| CY2018Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
949284 | USD |
| CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y1M6D | |
| CY2018Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y9M18D | |
| CY2018Q2 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
| CY2018Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-757811 | USD |
| CY2017Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-525698 | USD |
| CY2018 | eltp |
Intangible Assets Excluding Goodwill Acquired
IntangibleAssetsExcludingGoodwillAcquired
|
1293910 | USD |
| CY2018Q2 | eltp |
Intangible Assets Excluding Goodwill Acquired
IntangibleAssetsExcludingGoodwillAcquired
|
0 | USD |
| CY2018Q2 | eltp |
Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
|
-181547 | USD |
| CY2017Q2 | eltp |
Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
|
-205106 | USD |
| CY2018Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
168170 | USD |
| CY2018Q2 | dei |
Trading Symbol
TradingSymbol
|
ELTP | |
| CY2018Q2 | eltp |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
|
85377 | USD |
| CY2018 | eltp |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
|
79215 | USD |
| CY2018Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y6M | |
| CY2018Q2 | us-gaap |
Assets Current
AssetsCurrent
|
11457527 | USD |
| CY2018Q1 | us-gaap |
Assets Current
AssetsCurrent
|
13702401 | USD |
| CY2018Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
804650058 | shares |
| CY2018Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
802626761 | shares |
| CY2018Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1858394 | USD |
| CY2017Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2238271 | USD |
| CY2018Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
802526761 | shares |
| CY2018Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
804550058 | shares |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
90390 | USD |
| CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
60000 | USD |
| CY2018 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
244753 | USD |
| CY2018Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
810126509 | shares |
| CY2018Q2 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1364826 | USD |
| CY2017Q2 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-685002 | USD |
| CY2018Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
7713001 | USD |
| CY2018Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
7713001 | USD |
| CY2018Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
| CY2017Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
| CY2018Q2 | eltp |
Increase Decrease In Deferred Revenue And Customer Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerDeposits
|
-253333 | USD |
| CY2017Q2 | eltp |
Increase Decrease In Deferred Revenue And Customer Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerDeposits
|
-253334 | USD |
| CY2018Q2 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
902500 | USD |
| CY2018Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
60000 | USD |
| CY2018Q2 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
100000 | shares |
| CY2018Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
100000 | shares |
| CY2018Q2 | eltp |
Stock Issued During Period Value Additional Issues
StockIssuedDuringPeriodValueAdditionalIssues
|
2184 | USD |
| CY2018Q2 | us-gaap |
Interest Expense
InterestExpense
|
83138 | USD |
| CY2017Q2 | us-gaap |
Interest Expense
InterestExpense
|
70731 | USD |
| CY2018Q2 | eltp |
Change In Fair Value Of Warrant Derivatives
ChangeInFairValueOfWarrantDerivatives
|
252511 | USD |
| CY2017Q2 | eltp |
Change In Fair Value Of Warrant Derivatives
ChangeInFairValueOfWarrantDerivatives
|
139260 | USD |
| CY2018Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1709595 | USD |
| CY2017Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1091059 | USD |
| CY2018Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
| CY2017Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
| CY2018Q2 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
2161 | USD |
| CY2018Q2 | eltp |
Stock Issued During Period Shares Payment Of Employee Salaries
StockIssuedDuringPeriodSharesPaymentOfEmployeeSalaries
|
0 | shares |
| CY2018Q2 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
392820 | USD |
| CY2018Q1 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
391566 | USD |
| CY2017Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3000 | USD |
| CY2018Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-178558 | USD |
| CY2017Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-335827 | USD |
| CY2018Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3088528 | USD |
| CY2018Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
168193 | USD |
| CY2017Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
423770 | USD |
| CY2018Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
473498 | USD |
| CY2018Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1687766 | USD |
| CY2017Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2165760 | USD |
| CY2018Q2 | us-gaap |
Assets
Assets
|
28495252 | USD |
| CY2018Q1 | us-gaap |
Assets
Assets
|
30882608 | USD |
| CY2018Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2018Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1255 | USD |
| CY2017Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
3982 | USD |
| CY2018Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
170628 | USD |
| CY2017Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
72511 | USD |
| CY2018Q2 | us-gaap |
Security Deposit
SecurityDeposit
|
59805 | USD |
| CY2018Q1 | us-gaap |
Security Deposit
SecurityDeposit
|
81932 | USD |
| CY2018Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
36549 | USD |
| CY2018Q2 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
178558 | USD |
| CY2017Q2 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
275344 | USD |
| CY2018Q2 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
0 | USD |
| CY2017Q2 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
60483 | USD |
| CY2018Q2 | eltp |
Price Difference Between Exercise Price And Quoted Price
PriceDifferenceBetweenExercisePriceAndQuotedPrice
|
0.09 | |
| CY2018Q1 | eltp |
Price Difference Between Exercise Price And Quoted Price
PriceDifferenceBetweenExercisePriceAndQuotedPrice
|
0.10 | |
| CY2018Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
452625 | USD |
| CY2018Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1065435 | USD |
| CY2018Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1658137 | USD |
| CY2018Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1970197 | USD |
| CY2018Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1788571 | USD |
| CY2018Q2 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | USD |
| CY2017Q2 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
181909 | USD |
| CY2018Q2 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
75822 | USD |
| CY2018Q1 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
75822 | USD |
| CY2018Q2 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
546186 | USD |
| CY2018Q1 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
578841 | USD |
| CY2018Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4670973 | USD |
| CY2018Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5114704 | USD |
| CY2018Q2 | us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
186030 | USD |
| CY2017Q2 | us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
-160528 | USD |
| CY2018Q2 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD |
| CY2018Q2 | eltp |
Retirement Of Common Shares Pursuant To Issuance Of Series J Convertible Preferred Shares
RetirementOfCommonSharesPursuantToIssuanceOfSeriesJConvertiblePreferredShares
|
0 | USD |
| CY2017Q2 | eltp |
Retirement Of Common Shares Pursuant To Issuance Of Series J Convertible Preferred Shares
RetirementOfCommonSharesPursuantToIssuanceOfSeriesJConvertiblePreferredShares
|
20378631 | USD |
| CY2018Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
306841 | USD |
| CY2017Q2 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
39741 | USD |
| CY2018Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1533930 | USD |
| CY2017Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1021476 | USD |
| CY2018Q2 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
1511678 | USD |
| CY2018Q1 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
1508134 | USD |
| CY2018Q2 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
1200000 | USD |
| CY2018Q1 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
1200000 | USD |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7570803 | USD |
| CY2017Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
10983774 | USD |
| CY2018Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6036873 | USD |
| CY2017Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9962298 | USD |
| CY2018Q2 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
664718 | USD |
| CY2018Q1 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
623020 | USD |
| CY2018Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
41145 | USD |
| CY2018Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
41144 | USD |
| CY2018Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
6831791 | USD |
| CY2018Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
7292392 | USD |
| CY2018Q2 | us-gaap |
Interest Paid Net
InterestPaidNet
|
24044 | USD |
| CY2017Q2 | us-gaap |
Interest Paid Net
InterestPaidNet
|
19688 | USD |
| CY2018Q2 | us-gaap |
Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
|
0 | USD |
| CY2017Q2 | us-gaap |
Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
|
190434 | USD |
| CY2018Q2 | us-gaap |
Liabilities
Liabilities
|
11502764 | USD |
| CY2018Q1 | us-gaap |
Liabilities
Liabilities
|
12407096 | USD |
| CY2018Q2 | us-gaap |
Notes Issued1
NotesIssued1
|
0 | USD |
| CY2017Q2 | us-gaap |
Notes Issued1
NotesIssued1
|
1200000 | USD |
| CY2018Q2 | eltp |
Commitment Shares Issued
CommitmentSharesIssued
|
2161 | USD |
| CY2017Q2 | eltp |
Commitment Shares Issued
CommitmentSharesIssued
|
931182 | USD |
| CY2018Q2 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
13903960 | USD |
| CY2018Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
13903960 | USD |
| CY2018Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
804652 | USD |
| CY2018Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
802629 | USD |
| CY2018Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
146805221 | USD |
| CY2018Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
146602502 | USD |
| CY2018Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
306841 | USD |
| CY2018Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-144214504 | USD |
| CY2018Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-142526738 | USD |
| CY2018Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
28495252 | USD |
| CY2018Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
30882608 | USD |
| CY2018Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2333333 | shares |
| CY2017Q2 | eltp |
Fair Value Inputs Preferred Stock Trials
FairValueInputsPreferredStockTrials
|
200000 | shares |
| CY2018Q2 | eltp |
Common Stock Traded Percent
CommonStockTradedPercent
|
0.3 | pure |
| CY2018Q2 | eltp |
Common Stock Weighted Average Price Percent
CommonStockWeightedAveragePricePercent
|
0.97 | pure |
| CY2018Q2 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
14355 | shares |
| CY2018Q2 | eltp |
Stock Issued During Period Value Payment Of Consultants Fees
StockIssuedDuringPeriodValuePaymentOfConsultantsFees
|
54135 | USD |
| CY2018Q2 | eltp |
Warrants Outstanding Weighted Average Exercise Price
WarrantsOutstandingWeightedAverageExercisePrice
|
0.1521 | |
| CY2018Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
354223 | USD |
| CY2017Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
405410 | USD |
